Ngā hua rapu kaituhi

1

Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis mā Moses Rodriguez

I whakaputaina 2007

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
2

Seizures in Patients with Multiple Sclerosis mā Brendan Kelley, Moses Rodriguez

I whakaputaina 2009

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
3

Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. mā Moses Rodriguez, Sriram Sampath

I whakaputaina 1988

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
4

Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. mā Mark D. Lindsley, Moses Rodriguez

I whakaputaina 1989

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
5

CD8<sup>+</sup>T cells in multiple sclerosis mā Aleksandar Đenić, Bharath Wootla, Moses Rodriguez

I whakaputaina 2013

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
6

Is Multiple Sclerosis an Autoimmune Disease? mā Bharath Wootla, Makoto Eriguchi, Moses Rodriguez

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
7

Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mito... mā George Anderson, Moses Rodriguez, Russel J. Reíter

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
8

Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. mā Moses Rodriguez, Mabel L. Pierce, E A Howie

I whakaputaina 1987

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
9

PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation mā Jens O. Watzlawik, Arthur E. Warrington, Moses Rodriguez

I whakaputaina 2013

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
10

Multiple Sclerosis mā Hernan Nicolás Lemus, Arthur E. Warrington, Moses Rodriguez

I whakaputaina 2017

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
11

Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis mā D J Miller, KS Sanborn, JA Katzmann, Moses Rodriguez

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
12

Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis mā Claudia F. Lucchinetti, Wolfgang Brück, Moses Rodriguez, Hans Lassmann

I whakaputaina 1996

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
13

Ebola virus: Melatonin as a readily available treatment option mā George Anderson, Michaël Maes, Regina P. Markus, Moses Rodriguez

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
14

Surgical therapy for multiple sclerosis tremor: a 12‐year follow‐up study mā Anhar Hassan, J. Eric Ahlskog, Moses Rodriguez, Joseph Y. Matsumoto

I whakaputaina 2012

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
15

Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination mā Kevin D. Pavelko, Baziel G.M. van Engelen, Moses Rodriguez

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
16

Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. mā Moses Rodriguez, Kevin D. Pavelko, Catherine Mckinney, Julian L. Leibowitz

I whakaputaina 1994

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:
17

Cellular Mechanisms of Central Nervous System Repair by Natural Autoreactive Monoclonal Antibodies mā Brent R. Wright, Arthur E. Warrington, D Edberg, Moses Rodriguez

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
18

Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. mā Kunihiko Asakura, David J. Miller, Larry R. Pease, Moses Rodriguez

I whakaputaina 1998

Artigo

Tiaki ki tētahi rārangi

I tiakina i:
19

Enhancing CNS Repair in Neurological Disease mā Xiaohua Xu, Arthur E. Warrington, Allan J. Bieber, Moses Rodriguez

I whakaputaina 2011

Whiwhi kuputuhi katoa
Revisão

Tiaki ki tētahi rārangi

I tiakina i:
20

Targeting of IgMκ Antibodies to Oligodendrocytes Promotes CNS Remyelination mā Kunihiko Asakura, David J. Miller, Larry R. Pease, Moses Rodriguez

I whakaputaina 1998

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Artigo

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - Moses Rodriguez

Effectors of Demyelination and Remyelination in the CNS: Implications for Multiple Sclerosis mā Moses Rodriguez

Seizures in Patients with Multiple Sclerosis mā Brendan Kelley, Moses Rodriguez

Successful therapy of Theiler's virus-induced demyelination (DA strain) with monoclonal anti-Lyt-2 antibody. mā Moses Rodriguez, Sriram Sampath

Characterization of the inflammatory response in the central nervous system of mice susceptible or resistant to demyelination by Theiler's virus. mā Mark D. Lindsley, Moses Rodriguez

CD8<sup>+</sup>T cells in multiple sclerosis mā Aleksandar Đenić, Bharath Wootla, Moses Rodriguez

Is Multiple Sclerosis an Autoimmune Disease? mā Bharath Wootla, Makoto Eriguchi, Moses Rodriguez

Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mito... mā George Anderson, Moses Rodriguez, Russel J. Reíter

Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. mā Moses Rodriguez, Mabel L. Pierce, E A Howie

PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation mā Jens O. Watzlawik, Arthur E. Warrington, Moses Rodriguez

Multiple Sclerosis mā Hernan Nicolás Lemus, Arthur E. Warrington, Moses Rodriguez

Monoclonal autoantibodies promote central nervous system repair in an animal model of multiple sclerosis mā D J Miller, KS Sanborn, JA Katzmann, Moses Rodriguez

Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis mā Claudia F. Lucchinetti, Wolfgang Brück, Moses Rodriguez, Hans Lassmann

Ebola virus: Melatonin as a readily available treatment option mā George Anderson, Michaël Maes, Regina P. Markus, Moses Rodriguez

Surgical therapy for multiple sclerosis tremor: a 12‐year follow‐up study mā Anhar Hassan, J. Eric Ahlskog, Moses Rodriguez, Joseph Y. Matsumoto

Acceleration in the Rate of CNS Remyelination in Lysolecithin-Induced Demyelination mā Kevin D. Pavelko, Baziel G.M. van Engelen, Moses Rodriguez

Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. mā Moses Rodriguez, Kevin D. Pavelko, Catherine Mckinney, Julian L. Leibowitz

Cellular Mechanisms of Central Nervous System Repair by Natural Autoreactive Monoclonal Antibodies mā Brent R. Wright, Arthur E. Warrington, D Edberg, Moses Rodriguez

Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination. mā Kunihiko Asakura, David J. Miller, Larry R. Pease, Moses Rodriguez

Enhancing CNS Repair in Neurological Disease mā Xiaohua Xu, Arthur E. Warrington, Allan J. Bieber, Moses Rodriguez

Targeting of IgMκ Antibodies to Oligodendrocytes Promotes CNS Remyelination mā Kunihiko Asakura, David J. Miller, Larry R. Pease, Moses Rodriguez

Ngā utauta rapu:

Ngā marau whai pānga